Samsung Biologics

Also known as samsung biologics

Corporate InvestorIncheon, South KoreaFounded 2011
$9.1B
Assets Under Management
Incheon
Headquarters

About Samsung Biologics

Samsung Biologics is a corporate investor based in Incheon, South Korea. Founded in 2011. Reported AUM: 9052 USD millions.

Preferred Investment Types

Early StageEarly Stage: SeedEarly Stage: Start-upExpansion / Late StageVenture (General)

Preferred Sectors & Themes

BiotechnologyHealthcarePharmaceuticals

Preferred Geographies

AsiaEast and Southeast AsiaEmerging MarketsNorth AmericaOECD

Explore similar limited partners

Browse more corporate investors and other institutional investors by location and type in the LPbacked limited-partner database.

Frequently asked questions

What type of investor is Samsung Biologics?

Samsung Biologics is a corporate investor based in Incheon, South Korea, managing approximately $9.1B in assets.

Where is Samsung Biologics headquartered?

Samsung Biologics is headquartered in Incheon, South Korea.

How much does Samsung Biologics manage?

Samsung Biologics manages approximately $9.1B in assets under management.

When was Samsung Biologics founded?

Samsung Biologics was founded in 2011.

What does Samsung Biologics invest in?

Samsung Biologics focuses on Early Stage, Early Stage: Seed, Early Stage: Start-up, Expansion / Late Stage, Venture (General), Biotechnology, Healthcare, Pharmaceuticals.

How can I contact Samsung Biologics?

Verified contact details, key decision-makers, and investment preferences for Samsung Biologics are available on LPbacked. Create a free account to access them.